Annual Short Term Debt
$0.00
-$63.80 K-100.00%
31 December 2023
Summary:
Enveric Biosciences annual short term debt is currently $0.00, with the most recent change of -$63.80 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has risen by $0.00 (0.00%). ENVB annual short term debt is now -100.00% below its all-time high of $5.21 million, reached on 31 December 2018.ENVB Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
N/A
30 September 2024
Summary:
Enveric Biosciences quarterly short term debt is not available.ENVB Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENVB Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | - |
| 3 y3 years | 0.0% | - |
| 5 y5 years | -100.0% | - |
ENVB Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | |||
| 5 y | 5 years | -100.0% | |||
| alltime | all time | -100.0% |
Enveric Biosciences Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(-100.0%) |
| June 2023 | - | $9600.00(-74.1%) |
| Mar 2023 | - | $37.00 K(-42.0%) |
| Dec 2022 | $63.80 K(-40.6%) | $63.80 K(-28.2%) |
| Sept 2022 | - | $88.80 K(-20.1%) |
| June 2022 | - | $111.10 K(-0.1%) |
| Mar 2022 | - | $111.20 K(+3.5%) |
| Dec 2021 | $107.40 K(>+9900.0%) | $107.40 K(-27.7%) |
| June 2021 | - | $148.60 K(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2020 | - | $6.86 M(+26.0%) |
| June 2020 | - | $5.44 M(-32.4%) |
| Mar 2020 | - | $8.05 M(+65.0%) |
| Dec 2019 | $4.88 M(-6.3%) | $4.88 M(+10.1%) |
| Sept 2019 | - | $4.43 M(-11.6%) |
| June 2019 | - | $5.02 M(-3.3%) |
| Mar 2019 | - | $5.19 M(-0.4%) |
| Dec 2018 | $5.21 M(+8.4%) | $5.21 M(+44.4%) |
| Sept 2018 | - | $3.61 M(+31.2%) |
| June 2018 | - | $2.75 M(-25.1%) |
| Mar 2018 | - | $3.67 M(-23.6%) |
| Dec 2017 | $4.80 M(+37.4%) | $4.80 M(+15.1%) |
| Sept 2017 | - | $4.17 M(-7.5%) |
| June 2017 | - | $4.51 M(+3.6%) |
| Mar 2017 | - | $4.36 M(+24.7%) |
| Dec 2016 | $3.49 M(+182.7%) | $3.49 M(-15.5%) |
| Sept 2016 | - | $4.14 M(+194.0%) |
| June 2016 | - | $1.41 M(-4.7%) |
| Mar 2016 | - | $1.48 M(+491.0%) |
| Dec 2015 | $1.24 M(>+9900.0%) | - |
| Sept 2015 | - | $250.00 K(>+9900.0%) |
| Mar 2014 | - | $2000.00(0.0%) |
| Dec 2013 | $2000.00(-75.0%) | $2000.00(-93.0%) |
| Sept 2013 | - | $28.50 K(+14.0%) |
| June 2013 | - | $25.00 K(+25.0%) |
| Mar 2013 | - | $20.00 K(+150.0%) |
| Dec 2012 | $8000.00(-17.5%) | $8000.00(-17.5%) |
| Dec 2007 | $9700.00 | $9700.00(-59.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2007 | - | $24.20 K(-28.6%) |
| June 2007 | - | $33.90 K(+249.5%) |
| Dec 2006 | $9700.00(-6.7%) | $9700.00(-59.9%) |
| Sept 2006 | - | $24.20 K(-28.4%) |
| June 2006 | - | $33.80 K(+225.0%) |
| Dec 2005 | $10.40 K(-84.3%) | $10.40 K(-71.4%) |
| Sept 2005 | - | $36.40 K(-45.8%) |
| June 2005 | - | $67.10 K(+67.8%) |
| Mar 2005 | - | $40.00 K(-39.7%) |
| Dec 2004 | $66.30 K(+76.8%) | $66.30 K(-10.6%) |
| Sept 2004 | - | $74.20 K(+97.9%) |
| June 2004 | - | $37.50 K(0.0%) |
| Mar 2004 | - | $37.50 K(0.0%) |
| Dec 2003 | $37.50 K(-66.7%) | $37.50 K(-15.2%) |
| Sept 2003 | - | $44.20 K(-73.6%) |
| June 2003 | - | $167.50 K(+48.9%) |
| Mar 2003 | - | $112.50 K(0.0%) |
| Dec 2002 | $112.50 K(0.0%) | $112.50 K(0.0%) |
| Sept 2002 | - | $112.50 K(0.0%) |
| June 2002 | - | $112.50 K(0.0%) |
| Mar 2002 | - | $112.50 K(0.0%) |
| Dec 2001 | $112.50 K(+233.8%) | $112.50 K(0.0%) |
| Sept 2001 | - | $112.50 K(0.0%) |
| June 2001 | - | $112.50 K(-66.7%) |
| Mar 2001 | - | $337.70 K(+902.1%) |
| Dec 2000 | $33.70 K(-90.4%) | $33.70 K(-90.4%) |
| Sept 2000 | - | $351.90 K(0.0%) |
| June 2000 | - | $351.90 K(0.0%) |
| Mar 2000 | - | $351.90 K(-59.7%) |
| Dec 1999 | $351.90 K(-59.7%) | - |
| Dec 1998 | $872.30 K(+87.9%) | $872.30 K(+190.8%) |
| Sept 1998 | - | $300.00 K(+200.0%) |
| June 1998 | - | $100.00 K(0.0%) |
| Mar 1998 | - | $100.00 K(-78.5%) |
| Dec 1997 | $464.30 K(+240.6%) | $464.30 K(+364.3%) |
| Sept 1997 | - | $100.00 K(0.0%) |
| June 1997 | - | $100.00 K(0.0%) |
| Mar 1997 | - | $100.00 K(-26.6%) |
| Dec 1996 | $136.30 K | $136.30 K |
FAQ
- What is Enveric Biosciences annual short term debt?
- What is the all time high annual short term debt for Enveric Biosciences?
- What is Enveric Biosciences annual short term debt year-on-year change?
- What is the all time high quarterly short term debt for Enveric Biosciences?
What is Enveric Biosciences annual short term debt?
The current annual short term debt of ENVB is $0.00
What is the all time high annual short term debt for Enveric Biosciences?
Enveric Biosciences all-time high annual short term debt is $5.21 M
What is Enveric Biosciences annual short term debt year-on-year change?
Over the past year, ENVB annual short term debt has changed by -$63.80 K (-100.00%)
What is the all time high quarterly short term debt for Enveric Biosciences?
Enveric Biosciences all-time high quarterly short term debt is $8.05 M